The economic burden of fibromyalgia: A systematic literature review

Sarzi-Puttini, 2020, Fibromyalgia: an update on clinical characteristics, aetiopathogenesis and treatment, Nat Rev Rheumatol, 16, 645, 10.1038/s41584-020-00506-w Ursini, 2021, Fibromyalgia: a new facet of the post-COVID-19 syndrome spectrum? Results from a web-based survey, RMD Open, 7, 10.1136/rmdopen-2021-001735 D'Onghia, 2021, Fibromyalgia and obesity: A comprehensive systematic review and meta-analysis, Semin Arthritis Rheum, 51, 409, 10.1016/j.semarthrit.2021.02.007 Fitzcharles, 2018, Comorbid fibromyalgia: A qualitative review of prevalence and importance, Eur J Pain, 22, 1565, 10.1002/ejp.1252 Jones, 2015, The prevalence of fibromyalgia in the general population: a comparison of the American College of Rheumatology 1990, 2010, and modified 2010 classification criteria, Arthritis Rheumatol, 67, 568, 10.1002/art.38905 Arnold, 2008, Patient perspectives on the impact of fibromyalgia, Patient Educ Couns, 73, 114, 10.1016/j.pec.2008.06.005 McDonald, 2011, Musculoskeletal pain in the workforce: the effects of back, arthritis, and fibromyalgia pain on quality of life and work productivity, J Occup Environ Med, 53, 765, 10.1097/JOM.0b013e318222af81 Häuser, 2015, Fibromyalgia, Nat Rev Dis Primers, 1, 15022, 10.1038/nrdp.2015.22 D'Onghia, 2021, Fibromyalgia syndrome - a risk factor for poor outcomes following orthopaedic surgery: A systematic review, Semin Arthritis Rheum, 51, 793, 10.1016/j.semarthrit.2021.05.016 Choy, 2010, A patient survey of the impact of fibromyalgia and the journey to diagnosis, BMC Health Services Research, 10, 102, 10.1186/1472-6963-10-102 Lee, 2017, Determinants of quality of life in patients with fibromyalgia: A structural equation modeling approach, PLoS One, 12, 10.1371/journal.pone.0171186 Felts, 1989, The economic impact of the rheumatic diseases in the United States, J Rheumatol, 16, 867 Fautrel, 2002, Cost of illness studies in rheumatic diseases, Curr Opin Rheumatol, 14, 121, 10.1097/00002281-200203000-00008 Hughes, 2006, The impact of a diagnosis of fibromyalgia on health care resource use by primary care patients in the UK: an observational study based on clinical practice, Arthritis Rheum, 54, 177, 10.1002/art.21545 Hamilton, 2001, Frequency of attendance in general practice and symptoms before development of chronic fatigue syndrome: a case-control study, Br J Gen Pract, 51, 553 Gendelman, 2021, Utilisation of healthcare services and drug consumption in fibromyalgia: A cross-sectional analysis of the Clalit Health Service database, Int J Clin Pract, 75, e14729, 10.1111/ijcp.14729 Knapp, 2020, Economics and mental health: the current scenario, World Psychiatry, 19, 3, 10.1002/wps.20692 Akobundu, 2006, Cost-of-illness studies : a review of current methods, Pharmacoeconomics, 24, 869, 10.2165/00019053-200624090-00005 Jo, 2014, Cost-of-illness studies: concepts, scopes, and methods, Clin Mol Hepatol, 20, 327, 10.3350/cmh.2014.20.4.327 Larg, 2011, Cost-of-illness studies: a guide to critical evaluation, Pharmacoeconomics, 29, 653, 10.2165/11588380-000000000-00000 Hodgson, 1982, Cost-of-illness methodology: a guide to current practices and procedures, Milbank Mem Fund Q Health Soc, 60, 429, 10.2307/3349801 Tarricone, 2006, Cost-of-illness analysis. What room in health economics?, Health Policy, 77, 51, 10.1016/j.healthpol.2005.07.016 Lofland, 2004, A review of health-related workplace productivity loss instruments, Pharmacoeconomics, 22, 165, 10.2165/00019053-200422030-00003 Burton, 1999, The role of health risk factors and disease on worker productivity, J Occup Environ Med, 41, 863, 10.1097/00043764-199910000-00007 Shepard, 1999, Cost-effectiveness in Health and Medicine, 2, 91 Schirr-Bonnans, 2017, Cost of diabetic eye, renal and foot complications: a methodological review, Eur J Health Econ, 18, 293, 10.1007/s10198-016-0773-6 Molinier, 2008, Methodological considerations in cost of prostate cancer studies: a systematic review, Value Health, 11, 878, 10.1111/j.1524-4733.2008.00327.x Drummond, 2005, Common methodological flaws in economic evaluations, Med Care, 43, 5 von der Warth, 2020, Economic evaluations and cost analyses in posttraumatic stress disorder: a systematic review, Eur J Psychotraumatol, 11, 10.1080/20008198.2020.1753940 Mutyambizi, 2018, Cost of diabetes mellitus in Africa: a systematic review of existing literature, Global Health, 14, 3, 10.1186/s12992-017-0318-5 Shafie, 2018, Systematic review of economic burden of heart failure, Heart Fail Rev, 23, 131, 10.1007/s10741-017-9661-0 Wang, 2018, A Systematic Review of Cost-of-Illness Studies of Multimorbidity, Appl Health Econ Health Policy, 16, 15, 10.1007/s40258-017-0346-6 Wong, 2017, Cost-effectiveness analysis of vaccinations and decision makings on vaccination programmes in Hong Kong: A systematic review, Vaccine, 35, 3153, 10.1016/j.vaccine.2017.04.050 Hamberg-van Reenen, 2012, Worksite mental health interventions: a systematic review of economic evaluations, Occup Environ Med, 69, 837, 10.1136/oemed-2012-100668 Konnopka, 2020, Economic Burden of Anxiety Disorders: A Systematic Review and Meta-Analysis, Pharmacoeconomics, 38, 25, 10.1007/s40273-019-00849-7 Lesyuk, 2018, Cost-of-illness studies in heart failure: a systematic review 2004-2016, BMC Cardiovasc Disord, 18, 74, 10.1186/s12872-018-0815-3 Christensen, 2020, The cost of mental disorders: a systematic review, Epidemiol Psychiatr Sci, 29, e161, 10.1017/S204579602000075X König, 2019, The excess costs of depression: a systematic review and meta-analysis, Epidemiol Psychiatr Sci, 29, e30, 10.1017/S2045796019000180 Chan, 2017, Cost-of-illness studies in chronic ulcers: a systematic review, J Wound Care, 26, S4, 10.12968/jowc.2017.26.Sup4.S4 White, 1999, The London Fibromyalgia Epidemiology Study: direct health care costs of fibromyalgia syndrome in London, Canada, J Rheumatol, 26, 885 Berger, 2007, Characteristics and healthcare costs of patients with fibromyalgia syndrome, Int J Clin Pract, 61, 1498, 10.1111/j.1742-1241.2007.01480.x Berger, 2010, Patterns of healthcare utilization and cost in patients with newly diagnosed fibromyalgia, Am J Manag Care, 16, S126 Jeffery, 2014, Prevalence, health care utilization, and costs of fibromyalgia, irritable bowel, and chronic fatigue syndromes in the military health system, 2006-2010, Mil Med, 179, 1021, 10.7205/MILMED-D-13-00419 Johnston, 2014, Characteristics, treatment, and health care expenditures of Medicare supplemental-insured patients with painful diabetic peripheral neuropathy, post-herpetic neuralgia, or fibromyalgia, Pain Med, 15, 562, 10.1111/pme.12328 Knight, 2013, Health-resource use and costs associated with fibromyalgia in France, Germany, and the United States, Clinicoecon Outcomes Res, 5, 171, 10.2147/CEOR.S41111 Oliver, 2001, Effects of social support and education on health care costs for patients with fibromyalgia, J Rheumatol, 28, 2711 Painter, 2014, Healthcare Costs Associated With Chronic Opioid Use and Fibromayalgia Syndrome, Am J Pharm Benefits, 6 Park, 2016, Cost Burden of Chronic Pain Patients in a Large Integrated Delivery System in the United States, Pain Pract, 16, 1001, 10.1111/papr.12357 Robinson, 2003, Economic cost and epidemiological characteristics of patients with fibromyalgia claims, J Rheumatol, 30, 1318 Robinson, 2004, Depression and fibromyalgia: treatment and cost when diagnosed separately or concurrently, J Rheumatol, 31, 1621 Sanchez, 2011, Longitudinal evaluation of health care utilization and costs during the first three years after a new diagnosis of fibromyalgia, Curr Med Res Opin, 27, 663, 10.1185/03007995.2010.550605 Santoro, 2012, Fibromyalgia and hysterectomy: the impact on health status and health care costs, Clin Rheumatol, 31, 1585, 10.1007/s10067-012-2051-z Santoro, 2013, Depression, Self-Efficacy, Health Status, and Health Care Costs: A Comparison of Men with Fibromyalgia or Osteoarthritis, Journal of Musculoskeletal Pain, 21, 126, 10.3109/10582452.2013.795639 Schaefer, 2016, The Comparative Burden of Chronic Widespread Pain and Fibromyalgia in the United States, Pain Pract, 16, 565, 10.1111/papr.12302 Silverman, 2009, The economic burden of fibromyalgia: comparative analysis with rheumatoid arthritis, Curr Med Res Opin, 25, 829, 10.1185/03007990902728456 Thompson, 2011, Direct medical costs in patients with fibromyalgia: Cost of illness and impact of a brief multidisciplinary treatment program, Am J Phys Med Rehabil, 90, 40, 10.1097/PHM.0b013e3181fc7ff3 White, 2008, Employees with fibromyalgia: medical comorbidity, healthcare costs, and work loss, J Occup Environ Med, 50, 13, 10.1097/JOM.0b013e31815cff4b White, 2009, Comparison of health care use and costs in newly diagnosed and established patients with fibromyalgia, J Pain, 10, 976, 10.1016/j.jpain.2009.03.012 Wolfe, 1997, A prospective, longitudinal, multicenter study of service utilization and costs in fibromyalgia, Arthritis Rheum, 40, 1560, 10.1002/art.1780400904 Lacasse, 2016, Fibromyalgia-related costs and loss of productivity: a substantial societal burden, BMC Musculoskelet Disord, 17, 168, 10.1186/s12891-016-1027-6 Lachaine, 2010, Clinical and economic characteristics of patients with fibromyalgia syndrome, Clin J Pain, 26, 284, 10.1097/AJP.0b013e3181cf599f Penrod, 2004, Health services costs and their determinants in women with fibromyalgia, J Rheumatol, 31, 1391 Lamotte, 2010, Health economic evaluation of outpatient management of fibromyalgia patients and the costs avoided by diagnosing fibromyalgia in France, Clin Exp Rheumatol, 28, S64 Luciano, 2013, Cost-utility of a psychoeducational intervention in fibromyalgia patients compared with usual care: an economic evaluation alongside a 12-month randomized controlled trial, Clin J Pain, 29, 702, 10.1097/AJP.0b013e318270f99a Rivera, 2009, Resource utilisation and health care costs in patients diagnosed with fibromyalgia in Spain, Clin Exp Rheumatol, 27, S39 Rivera, 2012, Prospective study of the use of healthcare resources and economic costs in patients with fibromyalgia after treatment in routine medical practice, Clin Exp Rheumatol, 30, 31 Sicras-Mainar, 2009, Treating patients with fibromyalgia in primary care settings under routine medical practice: a claim database cost and burden of illness study, Arthritis Res Ther, 11, R54, 10.1186/ar2673 Winkelmann, 2011, Impact of fibromyalgia severity on health economic costs: results from a European cross-sectional study, Appl Health Econ Health Policy, 9, 125, 10.2165/11535250-000000000-00000 Liedgens, 2016, A burden of illness study for neuropathic pain in Europe, Clinicoecon Outcomes Res, 8, 113 Boonen, 2005, Large differences in cost of illness and wellbeing between patients with fibromyalgia, chronic low back pain, or ankylosing spondylitis, Ann Rheum Dis, 64, 396, 10.1136/ard.2003.019711 van Eijk-Hustings, 2013, Challenges in demonstrating the effectiveness of multidisciplinary treatment on quality of life, participation and health care utilisation in patients with fibromyalgia: a randomised controlled trial, Clin Rheumatol, 32, 199, 10.1007/s10067-012-2100-7 Vervoort, 2016, Cost of illness and illness perceptions in patients with fibromyalgia, Clin Exp Rheumatol, 34, S74 Doron, 2004, The clinical and economic burden of fibromyalgia compared with diabetes mellitus and hypertension among Bedouin women in the Negev, Fam Pract, 21, 415, 10.1093/fampra/cmh411 Gharibpoor, 2021, High cost of illness in fibromyalgia patients in Iran, irrespective of disease severity: A prospective cost study, Int J Rheum Dis, 24, 671, 10.1111/1756-185X.14094 Kim, 2013, Effect of fibromyalgia syndrome on the health-related quality of life and economic burden in Korea, Rheumatology (Oxford), 52, 311, 10.1093/rheumatology/kes255 Lee, 2016, Humanistic and economic burden of fibromyalgia in Japan, J Pain Res, 9, 967, 10.2147/JPR.S110707 Choy, 2010, A patient survey of the impact of fibromyalgia and the journey to diagnosis, BMC Health Serv Res, 10, 102, 10.1186/1472-6963-10-102 Macfarlane, 2017, EULAR revised recommendations for the management of fibromyalgia, Ann Rheum Dis, 76, 318, 10.1136/annrheumdis-2016-209724 Ben-Ami Shor, 2017, Adherence and Persistence with Drug Therapy among Fibromyalgia Patients: Data from a Large Health Maintenance Organization, J Rheumatol, 44, 1499, 10.3899/jrheum.170098 Skaer, 2014, Fibromyalgia: disease synopsis, medication cost effectiveness and economic burden, Pharmacoeconomics, 32, 457, 10.1007/s40273-014-0137-y Cadarette, 2015, An Introduction to Health Care Administrative Data, Can J Hosp Pharm, 68, 232 Ng, 2014, Cost-of-illness studies of diabetes mellitus: a systematic review, Diabetes Res Clin Pract, 105, 151, 10.1016/j.diabres.2014.03.020 Byford, 2000, Economic note: cost of illness studies, Bmj, 320, 1335, 10.1136/bmj.320.7245.1335 Bloom, 2001, Usefulness of US cost-of-illness studies in healthcare decision making, Pharmacoeconomics, 19, 207, 10.2165/00019053-200119020-00007 Dagenais, 2008, A systematic review of low back pain cost of illness studies in the United States and internationally, Spine J, 8, 8, 10.1016/j.spinee.2007.10.005